Bloomberg: JTI's 2023 Cigarette Shipment Volume Rises, the Only in 3 Tobacco Giants

JTI by 2FIRSTS
Feb.19.2024
Bloomberg: JTI's 2023 Cigarette Shipment Volume Rises, the Only in 3 Tobacco Giants
The difference in sales highlights JTI's differences in strategy. As PMI and BAT shift more research and marketing resources towards alternative products including e-cigarettes, heated tobacco, and nicotine pouches, JTI is more inclined to try to increase market share and sales in traditional cigarettes.

Japan Tobacco International (JTI), the parent company headquartered in Geneva, announced during the release of its annual financial report that the total sales volume of JTI's cigarette brands Winston and Camel increased by 2.3% in 2023.

 

For comparison, Philip Morris International Inc. transported approximately 613 billion cigarettes in 2023, a decrease of 1.3% from the previous year. British American Tobacco Plc manufactured and transported approximately 555 billion cigarettes last year, a decrease of 8.2% from 2022.

 

Philip Morris International (PMI) has reported that about one-third of its revenue now comes from smoke-free alternatives, and it plans to increase this proportion to half by 2025. In its recent annual performance report, PMI announced that net revenue from its IQOS heated tobacco product surpassed its flagship brand, Marlboro, in the fourth quarter.

 

British American Tobacco (BAT) revealed in its annual performance report that its alternative products, including Vuse e-cigarettes and Velo nicotine pouches, are now profitable earlier than previously expected.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai
China’s Tobacco Regulator Moves to Introduce Credit Management Framework for E-Cigarette Manufacturers, Greater Transparency May Improve International Assessability of China’s Supply Chain
China’s Tobacco Regulator Moves to Introduce Credit Management Framework for E-Cigarette Manufacturers, Greater Transparency May Improve International Assessability of China’s Supply Chain
China’s tobacco regulator has moved to introduce a credit management framework for e-cigarette manufacturers, outlining a system that links compliance records to regulatory oversight. The proposal forms part of a broader push to institutionalize supervision and improve transparency across China’s e-cigarette supply chain.
Jan.05
Japan Tobacco expands Ploom EVO stick lineup, rolling out four new variants in Japan in two phases
Japan Tobacco expands Ploom EVO stick lineup, rolling out four new variants in Japan in two phases
Japan Tobacco (JT) is adding four new EVO variants for its Ploom heated tobacco range—Green Mint, Cacao Mint Crystal, Tropical Lime Crystal and Sakura Regular—set to launch in two waves on Jan. 22 and Feb. 3. The initial release will be via the CLUB JT online store and Ploom retail stores.
Jan.23 by 2FIRSTS.ai
South Dakota Senate Committee Advances Bill Tightening Nicotine Retail Rules
South Dakota Senate Committee Advances Bill Tightening Nicotine Retail Rules
South Dakota Senate Bill 221 (SB 221), which seeks to regulate the retail sale of nicotine products, has passed the Senate Health and Human Services Committee with a unanimous 7–0 recommendation. The bill was significantly amended, expanding from three to nine pages and shifting its focus from vapor products alone to all nicotine products.
Regulations
Feb.22
KT&G’s Heated Tobacco Brand “lil” Named to Korea’s Brand Hall of Fame for Eighth Consecutive Year
KT&G’s Heated Tobacco Brand “lil” Named to Korea’s Brand Hall of Fame for Eighth Consecutive Year
KT&G said its heated tobacco brand “lil” was selected as an outstanding brand in the heated tobacco category of the “2026 Korea Brand Hall of Fame,” marking its eighth straight year on the list. The awards are organized by the Industrial Policy Research Institute (IPS) and determined through a composite evaluation of customer satisfaction, brand value and market performance.
Jan.26 by 2FIRSTS.ai